Lanqing Li

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Breast Cancer Cells

Endoplasmic Reticulum Stress

Top Venues

BioFactors (Oxford, England)

Phytotherapy research : PTR

This page only lists publications with an associated author ORCID identifier.

Publications

Lanqing Li, Haiying Xu, Linghang Qu, Kang Xu, Xianqiong Liu
Daidzin inhibits hepatocellular carcinoma survival by interfering with the glycolytic/gluconeogenic pathway through downregulation of TPI1. BioFactors (Oxford, England) 48 (4) (2022)
Haiying Xu, Lanqing Li, Linghang Qu, Jiyuan Tu, Xiongjie Sun, Xianqiong Liu, Kang Xu
Atractylenolide-1 affects glycolysis/gluconeogenesis by downregulating the expression of TPI1 and GPI to inhibit the proliferation and invasion of human triple-negative breast cancer cells. Phytotherapy research : PTR (2022)